Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia. [electronic resource]
Producer: 20051209Description: 7936-41 p. digitalISSN:- 0732-183X
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Child
- Child, Preschool
- Combined Modality Therapy
- Cranial Irradiation
- Etoposide -- administration & dosage
- Female
- Humans
- Infant
- Male
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- mortality
- Prognosis
- Remission Induction
- Risk Factors
- Survival Rate
- Teniposide -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.